Anything relating to the treatment and therapy available for CML
You are here
Treating CML
Recently diagnosed - options and outlook
Being diagnosed with chronic myeloid leukaemia (CML) can bring many questions - but we have great treatments available.
In these videos, Dr Ali Mahdi explains the treatment options available and what you can expect for the future. With modern therapies, most people with CML live full, active lives, and outcomes continue to improve every year.
Joanna Large, CNS, shares guidance on where to find practical and emotional support, helping you connect with resources that make day‑to‑day life a little easier.
- Read more about Recently diagnosed - options and outlook
- Log in or register to post comments
Diagnosing, Testing, and Monitoring Chronic Myeloid Leukaemia: A guide for patients
This booklet provides an overview of the quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) test. It includes a description of the qRT-PCR International Standardisation (IS) project within the context of the recently updated (2013) ELNet Recommendations and NCCN Treatment Guidelines for the treatment and management of Ph+CML based on molecular testing by qRT-PCR. Click on the picture of the booklet cover below to open it.
Generic Imatinib Leaflet
- Read more about Generic Imatinib Leaflet
- Log in or register to post comments
Our Publications
CML Support publish booklets and leaflets to help people understand PH+CML.
Quantitative Reverse Transcription Polymerase Chain Reaction: A primer for patients
This booklet provides an overview of the quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) test. It includes a description of the qRT-PCR International Standardisation (IS) project within the context of the European Leukaemia Net Recommendations and NCCN Treatment Guidelines for the treatment and management of Ph+CML based on molecular testing by qRT-PCR.
In this section
- Read more about Our Publications
- Log in or register to post comments
Brian Druker: Meeting the New Challenges in CML Therapy
CML Treatment Guidelines (TKI)
EPIC
Ponatinib in Newly Diagnosed CML
Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia
Panobinostat and imatinib mesylate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth
DASFREE
Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response.
